New hope to avoid colostomy bags: triple therapy tested for rectal cancer
NCT ID NCT05215379
Summary
This study tested whether adding immunotherapy to standard chemotherapy and radiation before surgery could improve outcomes for people with a specific type of ultra-low rectal cancer. The goal was to shrink tumors enough so surgeons could avoid removing the anus, allowing patients to avoid a permanent colostomy bag. Researchers compared the new combination to the standard treatment in 201 patients to see if it led to more complete tumor disappearance and better organ preservation.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Colorectal Surgery in Changhai Hospital
Shanghai, Shanghai Municipality, 200433, China
Conditions
Explore the condition pages connected to this study.